HPV Testing Evidence Examined In Cervical Cancer Screening Guidelines
This article was originally published in The Gray Sheet
Executive SummaryThe U.S. Preventive Services Task Force finds the evidence inconclusive for employing human papillomavirus testing as part of cervical cancer screening for women over 30, and it explicitly recommends against HPV testing in younger women.
You may also be interested in...
The Microbiology Devices Panel provided unanimous support Roche’s submission to upgrade labeling for it cobas HPV test as a first-line, primary screen for cervical cancer.
Abbott earns approval in Japan for Xience Xpedition everolimus-eluting stent. Zimmer will distribute SpineCraft’s APEX system. More new product news.
Sanofi picks up Pluromed. Arriva Medical buys AmMed Direct. Sanuwave gives PMA status update. More news briefs.